Eris Lifesciences Ltd on Monday reported a 39.16 per cent rise in consolidated net profit to ₹187.14 crore in the September quarter, driven by growth in its domestic branded formulations business. The company had posted a net profit of ₹134.47 crore in the same period of the previous fiscal year, Eris Lifesciences Ltd said in a regulatory filing. Total revenue from operations in the second quarter was ₹892.37 crore as against ₹792.41 crore in the year-ago period, it added.
No articles in the last 24 hours. Expand to 1 week
